COO of PDX Pharma has been named on Portland Business Journal’s 40 Under 40 For 2024

Congratulations to Dr. Worapol (Boom) Ngamcherdtrakul for Being Named a 2024 ’40 Under 40′ Honoree!

We are thrilled to announce that our Head of Research & COO, Dr. Worapol Ngamcherdtrakul, has been named one of Portland Business Journal’s prestigious ’40 Under 40′ honorees for 2024! This recognition highlights his exceptional contributions to cancer research and nanotechnology, particularly his leadership in advancing cancer immunotherapy through our innovative Pdx-NP™ nanoparticle technology.

Each year, Portland Business Journal selects forty of the region’s most influential professionals to represent Oregon and Southwest Washington. This top honor recognizes executives who are making significant impacts on their industries and communities. Join us in celebrating Dr. Ngamcherdtrakul’s well-deserved honor and unwavering commitment to cancer research. His leadership and vision are driving us toward groundbreaking treatments and improved patient outcomes.

Check out his story: https://lnkd.in/giUH3Zwx